logo-loader
viewParagon Diamonds Ltd

Paragon Diamonds eyes revenues of US$160mln from two Lesotho mines

Combined annual revenue could be approximately US$160mln and profits approximately US$97mln, said the company.

rsz_gem_diamonds_558d2a3d81449.jpg
At full operational capacity Paragon expects to be a 5Mln tonne per year producer.

Paragon Diamonds (LON:PDG) has confirmed it will fast-track its mines at Lemphane and Mothae in Lesotho into production this year.

At full operational capacity (within the next three years) Paragon expects to be a 5Mln tonne per year producer of in excess of 100,000 exceptional carats with average values exceeding US$1,500/carat at current prices.

This could generate combined annual revenue of approximately US$160mln and combined profit of approximately US$97mln, said the company.

In the first year when both mines are in full production, Paragon expects combined revenues of approximately US$36mln.

Once in production, executive chairman Philip Falzon Sant Maduca said Paragon will have “a first class platform from which to operate and build a fully vertically integrated diamond company.” 

Mothae’s acquisition remains subject to government approval, though the company had previously reported a constructive meeting with the Lesotho Minister of Mining on 22 June.

For the year to end December 2014, Paragon posted a loss of £13.4mln (£1.3mln).

Shares rose 1% to 5.56p.

Quick facts: Paragon Diamonds Ltd

Price: - -

AIM:PRG
Market: AIM
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...

3 hours, 10 minutes ago

2 min read